University of Pennsylvania’s School of Veterinary Medicine to Evaluate New Gastrointestinal Panel Using LexaGene’s MiQLab System
17 August 2022 - 10:00PM
LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG)
(“LexaGene” or the “Company”), an innovative, molecular diagnostics
company that has commercialized the MiQLab® System for automated,
genetic syndromic testing for veterinarians, announces the start of
an evaluation of a gastrointestinal (GI) pathogen panel, in the
laboratory of Stephen Cole, MS, VMD, DACVM at the University of
Pennsylvania’s School of Veterinary Medicine (Penn Vet).
Dr. Jack Regan, LexaGene’s Founder and CEO
stated, “GI issues such as acute diarrhea are the most common
reason why companion animal owners bring their pet to see a
veterinarian.1 Rapidly diagnosing GI issues caused by pathogenic
bacteria, protozoans, and viruses is difficult with standard
microscopy and rapid tests are either lacking or poor in
sensitivity. LexaGene is excited to have started this study to
prove our technology solves this pain point for veterinarians.”
Dr. Nathan Walsh, LexaGene’s VP of Applications
and Bioinformatics stated, “Our GI panel screens for 5 bacteria, 11
toxins genes that are commonly associated with acute diarrhea, 4
protozoans, and a virus family that includes common GI viruses.
These pathogens and toxins are commonly responsible for
gastrointestinal distress and knowing the identity of the pathogen
and toxin genes helps guide treatment decisions.”
The MiQLab GI Pathogen Panel specifically
screens for the following pathogens:
5 bacteria |
CampylobacterClostridium difficileClostridium perfringens
Escherichia coliSalmonella |
11 toxins from the following bacteria: |
Clostridium difficileClostridium perfringensenteropathogenic E.
coli (EPEC)enterohemorrhagic E. coli (EHEC) enteroaggregative E.
coli (EAEC) necrotoxic E. coli (NTEC)enterotoxigenic E. coli
(ETEC)enteroinvasive E. coli (EIEC) |
Protozoans |
Cryptosporidium GiardiaToxoplasma gondiiTritrichomonas |
A virus family |
Detects canine parvovirus and feline panleukopenia virus |
For more information about LexaGene and the MiQLab System,
please visit www.lexagene.com or follow us on Twitter or
LinkedIn.
About LexaGene Holdings
Inc.LexaGene is a molecular diagnostics company that has
commercialized the MiQLab System for fast and easy detection of
pathogens and other molecular markers. The System is designed for
on-site usage and uses real-time PCR chemistry. Our customers
include veterinary hospitals and reference laboratories – as well
as contract biologic manufacturers. The MiQLab System delivers
excellent sensitivity, specificity, and breadth of detection.
The TSX Venture Exchange Inc. has in no way
passed upon the merits of the proposed transaction and has neither
approved nor disapproved the contents of this press release.
Neither TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
This news release contains forward-looking
information, which involves known and unknown risks, uncertainties
and other factors that may cause actual events to differ materially
from current expectation. Important factors -- including the
availability of funds, the results of financing efforts, the
success of technology development efforts, the cost to procure
critical parts, performance of the instrument, market acceptance of
the technology, regulatory acceptance, and licensing issues -- that
could cause actual results to differ materially from the Company's
expectations as disclosed in the Company's documents filed from
time to time on SEDAR (see www.sedar.com). Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
The company disclaims any intention or obligation, except to the
extent required by law, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise.
1
https://todaysveterinarypractice.com/news/top-10-reasons-why-pets-see-a-veterinarian/
T 800.215.1824 | info@lexagene.com
Lexagene (TSXV:LXG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lexagene (TSXV:LXG)
Historical Stock Chart
From Apr 2023 to Apr 2024